Clyde Pharmaceutical Private Limited, a active private limited company, was established on 20 October 2011 in Khopoli, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74900MH2011PTC223301. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vishnu Dutta Agrawal (Director), Kuldeep Kumar (Director), Purnima Adlakha (Director). Past directors included Kuldeep Kumar, Sarvodaya Chitkara. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bldg D-8 Arihant Garden, Khopoli, Maharashtra, 410203.
U47721MH2011PTC223301
223301
20 October 2011
₹0.20 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Clyde Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishnu Dutta Agrawal | Director | 14 Jun 2012 | Current |
| Kuldeep Kumar | Director | 24 Apr 2023 | Current |
| Purnima Adlakha | Director | 20 Oct 2011 | Current |
| Neelam Suri | Director | 10 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Aug 2018 | Past |
| Pramod Abcsdd | Director | 13 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Clyde Pharmaceutical Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 0.14% decrease. The company also saw a substantial improvement in profitability, with a 222.77% increase in profit. The company's net worth Soared by an impressive increase of 29.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Clyde Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Clyde Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Clyde Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clyde Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Clyde Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Clyde Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Kuldeep Kumar was appointed as a Director was appointed as a Director on 24 Apr 2023 & has been associated with this company since 2 years 7 months . was documented.
The activity Neelam Suri was appointed as a Director was appointed as a Director on 10 Mar 2014 & has been associated with this company since 11 years 8 months . was completed.
Progress on Vishnu Dutta Agrawal was appointed as a Director was appointed as a Director on 14 Jun 2012 & has been associated with this company since 13 years 5 months . was documented.
Purnima Adlakha was appointed as a Director was appointed as a Director on 20 Oct 2011 & has been associated with this company since 14 years 1 month . was recorded as a recent event.
The CIN of Clyde Pharmaceutical Private Limited is U47721MH2011PTC223301.
Clyde Pharmaceutical Private Limited is headquartered at Bldg D-8 Arihant Garden, Khopoli, Maharashtra, 410203.
Clyde Pharmaceutical Private Limited was incorporated on 20 October 2011.
The current directors of Clyde Pharmaceutical Private Limited are
The primary industry of Clyde Pharmaceutical Private Limited is Pharma.
Clyde Pharmaceutical Private Limited is unlisted.
The authorized capital of Clyde Pharmaceutical Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Clyde Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX